Preloader
Global Computational Biology Market Size, Trends and Growth Opportunity, by Application (Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software), by Services (In-house, Contract), by End Use (Academics & Research, Commercial): Global Opportunity Analysis and Industry Forecast, 2021-2027.


Report ID : IR100661 | Industries : Healthcare | Published On :May 2024 | Page Count : 243

  • Request Sample      Ask for Customization     Inquire Before Buying     Speak to Analyst



  • Global Computational Biology Market Size, Trends and Growth Opportunity, by Application (Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software), by Services (In-house, Contract), by End Use (Academics & Research, Commercial): Global Opportunity Analysis and Industry Forecast, 2021-2027.
    Global Computational Biology Market 
    Global Computational Biology Market was valued at USD 4.12 million in 2022 and is slated to reach at USD 12.94 million by 2027 at a CAGR of 21.84% from 2022-2027.
    Computational biology referred as development and application of data analytical and theoretical methods, computational simulation, and mathematical modeling techniques which are used for study of biological systems. This is multifaceted field and that combines the principles of applied animation, computer science, anatomy, biophysics, biochemistry, ecology, and genomics. Also, computational biology includes bioinformatics and the science of using biological data to develop algorithms to understand biological systems and its relationships.
    Market Drivers
    Increase in number of clinical studies and in pharmacokinetics and pharmacogenomics for new drug discovery and development is considered as key driving factor which is expected to boost the global computational biology market growth. Furthermore, increase in demand for predictive models and funding from governments and private enterprises for research and development activities will positively contribute the market growth. Moreover, increase in use of computational tools in epi-genomics, genomics, proteomics, and meta genomics to understand 3D protein structural analysis, gene sequencing coupled with research activities in new drug designing process which expected to drive the market growth.  
    Market Restraints
    However, lack of trained professionals is the major restraining factor which is expected to hinder the global computational biology market growth.
    Impact of COVID-19
    The market for computational biology has been impacted by the COVID-19 epidemic. Governments all across the world have imposed severe restrictions, including border locks, lockdowns, and stringent social segregation measures, to stop the spread of COVID-19. These actions had a big effect on the world economy, affecting many different industries. Governments from all around the world are collaborating with pharmaceutical and biotech businesses to combat the COVID-19 outbreak, from fostering the creation of vaccinations to preparing for issues with the distribution of medical supplies.
    Recent development
    April 2022- 30 newly hired employees, including six newly hired employees based in India and one newly hired employee based in Japan, received non-statutory stock options to purchase a total of 101,715 shares of the company's common stock, according to a press release from Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is revolutionising the way therapeutics and materials are discovered.
    Ajinomoto, a global supplier of cell culture media and development and manufacturing services (CDMO) to the biopharmaceutical industry, has implemented Genedata Bioprocess® to digitalize and automate their R&D and manufacturing operations in Japan and Korea, according to Genedata, the leading provider of enterprise software solutions for the biopharmaceutical research and development industry.
    Market segmentation
    Global Computational Biology Market is segmented into services such as In-House, and Contract, by application such as Human Body Simulation Software, Preclinical Drug Development, Cellular & Biological Simulation, Clinical Trials, and Drug Discovery & Disease Modeling. Further, market is segmented into end user such as Academics, and Commercial.
    Regional Analysis
    Also, Global Computational Biology Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
    Market key Players
    Various key players are discussed in this report such as Genedata AG, Chemical Computing Group Inc., Nimbus Discovery Plc., Simulation Plus Inc, Dassault Systems, Compugen Ltd., Insilico Biotechnology AG, and Leadscope Inc.
    Market Taxonomy
    By Service
    • In-House
    • Contract
    By Application
    • Human Body Simulation Software
    • Preclinical Drug Development
    • Cellular & Biological Simulation
    • Clinical Trials
    • Drug Discovery & Disease Modeling
    By End User
    • Academics
    • Commercial
    By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa

    "
     

    Global Computational Biology Market TOC:

    1 Introduction 
    1.1 Objective of the Study
    1.2 Market definition
    1.3 Market Scope

    2 Research Methodology
    2.1 Data Mining
    2.2 Validation
    2.3 Primary Interviews
    2.4 List of Data Sources

    3 Executive Summary
    4 Global Computational Biology Market Outlook
    4.1 Overview
    4.2 Market Dynamics
    4.2.1 Drivers
    4.2.2 Restraints
    4.2.3 Opportunities
    4.3 Porters Five Force Model
    4.4 Value Chain Analysis

    5  Global Computational Biology Market, By Service
    5.1 Y-o-Y Growth Comparison, By Service 
    5.2 Global Computational Biology Market Share Analysis, By Service 
    5.3 Global Computational Biology Market Size and Forecast, By Service
    5.3.1 In-House
    5.3.2  Contract

    6  Global Computational Biology Market , By Application
    6.1 Y-o-Y Growth Comparison, By Application
    6.2 Global Computational Biology Market Share Analysis, By Application
    6.3 Global Computational Biology Market Size and Forecast, By Application
    6.3.1 Human Body simulation Software
    6.3.2 Preclinical Drug Development
    6.3.3. Cellular & Biological Simulation
    6.3.4. Clinical Trials
    6.3.5. Drug Discovery & Disease Modelling

    7  Global Computational Biology Market, End User
    7.1 Y-o-Y Growth Comparison, End User
    7.2 Global Computational Biology Market Share Analysis, End User
    7.3 Global Computational Biology Market Size and Forecast, End User
    7.3. 1.Academics
    7.3.2 Commercial

    8Global Computational Biology Market, By Region
    8.1 Global Computational Biology Market Share Analysis, By Region
    8.2 Global Computational Biology Market Share Analysis, By Region
    8.3 Global Computational Biology Market Size and Forecast, By Region

    9 North America Computational Biology Market Analysis and Forecast (2022 – 2027)
    9.1 Introduction
    9.2 North America Computational Biology Market Share Analysis, By Service
    9.3 North America Computational Biology Market Size and Forecast, By Application
    9.4 North America Computational Biology Market Size and Forecast, End User
    9.5 North America Computational Biology Market Size and Forecast, By Country
    9.5.1 U.S.
    9.5.2 Canada
    9.5.3 Mexico

    10EuropeComputational Biology Market Analysis and Forecast (2022 – 2027)
    10.1 Introduction
    10.2 Europe Computational Biology Market Share Analysis, By Service 
    10.3 Europe Computational Biology Market Size and Forecast, By Application 
    10.4 Europe Computational Biology Market Size and Forecast, End User
    10.5 Europe Computational Biology Market Size and Forecast, By Country
    10.5.1 Germany
    10.5.2 France
    10.5.3 UK
    10.54. Rest of Europe

    11Asia Pacific Computational Biology Market Analysis and Forecast (2022 – 2027)
    11.1 Introduction
    11.2 Asia Pacific Computational Biology Market Share Analysis, By Service 
    11.3 Asia Pacific Computational Biology Market Size and Forecast, By Application 
    11.4 Asia Pacific Computational Biology Market Size and Forecast, End User
    11.5 Asia Pacific Computational Biology Market Size and Forecast, By Country
    11.5.1 China 
    11.5.2 Japan
    11.5.3 India
    11.5.4. Rest of Asia Pacific

    12Latin America Computational Biology Market Analysis and Forecast (2022 – 2027)
    12.1 Introduction
    12.2 Latin America Computational Biology Market Share Analysis, By Service 
    12.3 Latin America Computational Biology Market Size and Forecast, By Application 
    12.4 Latin America Computational Biology Market Size and Forecast, End User
    12.5 Latin America Computational Biology Market Size and Forecast, Country

    13Middle East Computational Biology Market Analysis and Forecast (2022 – 2027)
    13.1 Introduction
     13.2 Middle East Computational Biology Market Share Analysis, By Service 
    13.3 Middle East Computational Biology Market Size and Forecast, By Application 
    13.4 Middle East Computational Biology Market Size and Forecast, End User
    13.5 Middle East Computational Biology Market Size and Forecast, By Country
    14Competitive Analysis
    14.1 Competition Dashboard
    14.2 Market share Analysis of Top Vendors
    14.3 Key Development Strategies

    15Company Profiles

    15.1 Genedata AG,
    15.1.1 Overview
    15.1.2 Offerings
    15.1.3 Key Financials
    15.1.4 Business Segment & Geographic Overview
    15.1.5 Key Market Developments
    15.1.6 Key Strategies

    15.2 Chemical Computing Group Inc
    15.2.1 Overview
    15.2.2 Offerings
    15.2.3 Key Financials
    15.2.4 Business Segment & Geographic Overview
    15.2.5 Key Market Developments
    15.2.6 Key Strategies

    15.3 Nimbus Discovery Plc
    15.3.1 Overview
    15.3.2 Offerings
    15.3.3 Key Financials
    15.3.4 Business Segment & Geographic Overview
    15.3.5 Key Market Developments
    15.3.6 Key Strategies

    15.4 Simulation Plus Inc
    15.4.1 Overview
    15.4.2 Offerings
    15.4.3 Key Financials
    15.4.4 Business Segment & Geographic Overview
    15.4.5 Key Market Developments
    15.4.6 Key Strategies

    15.5 Dassault Systems
    15.5.1 Overview
    15.5.2 Offerings
    15.5.3 Key Financials
    15.5.4 Business Segment & Geographic Overview
    15.5.5 Key Market Developments
    15.5.6 Key Strategies

    15.6 Compugen Ltd
    15.6.1 Overview
    15.6.2 Offerings
    15.6.3 Key Financials
    15.6.4 Business Segment & Geographic Overview
    15.6.5 Key Market Developments
    15.6.6 Key Strategies

    15.7 Insilico Biotechnology AG
    15.7.1 Overview
    15.7.2 Offerings
    15.7.3 Key Financials
    15.7.4 Business Segment & Geographic Overview
    15.7.5 Key Market Developments
    15.7.6 Key Strategies 

    15.8 Leadscope Inc
    15.8.1 Overview
    15.8.2 Offerings
    15.8.3 Key Financials
    15.8.4 Business Segment & Geographic Overview
    15.8.5 Key Market Developments
    15.8.6 Key Strategies 


    "